Coronavirus information

Visitor restrictions, information for patients and more.

View coronavirus information

FOI 3945 Biologics and Biosimilar Prescribing

Home > Uncategorized > FOI 3945 Biologics and Biosimilar Prescribing

September 10, 2015

Last updated: September 10, 2015

Biologics and biosimilar prescribing. Please provide me with the following numbers of patients treated in the last six months with the following drugs for any condition.

Drug No. Patients
ABATACEPT 20
ADALIMUMAB 461
CERTOLIZUMAB PEGOL 26
ETANERCEPT 221
GOLIMUMAB 65
INFLIXIMAB 120
RITUXIMAB  Intravenous Infusion * 33
RITUXIMAB 1000 mg in 600ml Sodium Chloride 0.9% Infusion * 59
RITUXIMAB 1400 mg Subcutaneous Injection * 37
RITUXIMAB 500 mg in 300ml Sodium Chloride 0.9% Infusion * 2
RITUXIMAB 600 mg in 560ml Sodium Chloride 0.9% Infusion * 32
RITUXIMAB 700 mg in 570ml Sodium Chloride 0.9% Infusion * 38
RITUXIMAB 800 mg in 580ml Sodium Chloride 0.9% Infusion * 29
USTEKINUMAB 38

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.